Research Article
Association of Calcium and Phosphate Levels with Incident Chronic Kidney Disease in Patients with Hypoparathyroidism: A Retrospective Case-Control Study
Table 2
Association between albumin-corrected serum calcium and development of CKD.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CCI: Charlson comorbidity index; CI: confidence interval; CKD: chronic kidney disease. Models were run for the proportion outside, above, and below the range. Matching for groups was 1:1 based on age ± 5 years, sex, index date ± 1 year, and exposure window duration. Adjusted models were adjusted for the following baseline characteristics: age (continuous variable), index year (continuous variable), race (White vs Black, Asian, multi, other, or unknown), hypertension, type 2 diabetes, any acute hypoparathyroidism event (event of cardiac dysrhythmia, hypercalcemia, hypocalcemia, laryngeal spasm, muscle spasm, other convulsions, palpitations, tachycardia, tetanic cataract, or tetany), and CCI. †The target range for albumin-corrected serum calcium in patients with chronic hypoparathyroidism is defined as 2.00–2.25 mmol/L (8.0–9.0 mg/dL), which is different from the normal population reference range (2.15–2.55 mmol/L; 8.6–10.2 mg/dL). ‡Denotes any value < 0.05. |